Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility

Abstract

Killer immunoglobulin-like receptors (KIRs) are expressed on natural killer cells and some T-cell subsets and produce either activation or inhibitory signals upon binding with the appropriate human leucocyte antigen (HLA) ligand on target cells. Recent genetic association studies have implicated KIR genotype in the development of several inflammatory conditions. Ulcerative colitis (UC) is an inflammatory disorder of the colonic mucosa that results from an inappropriate activation of the immune system driven by host bacterial flora. We developed a polymerase chain reaction-sequence specific primer (SSP)-based assay to genotype 194 UC patients and 216 control individuals for 14 KIR genes, the HLA-Cw ligand epitopes of the KIR2D receptors and a polymorphism of the lectin-like-activating receptor NKG2D. Initial analysis found the phenotype frequency of KIR2DL2 and -2DS2 to be significantly increased in the UC cohort (P=0.030 and 0.038, respectively). Logistic regression analysis revealed a protective effect conferred by KIR2DL3 in the presence of its ligand HLA-Cw group 1 (P=0.019). These results suggest that KIR genotype and HLA ligand interaction may contribute to the genetic susceptibility of UC.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Rubin GP, Hungin AP, Kelly PJ, Ling J . Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000; 14: 1553–1559.

    Article  CAS  Google Scholar 

  2. Bouma G, Strober W . The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521–533.

    Article  CAS  Google Scholar 

  3. Duerr RH, Barmada MM, Zhang L, Davis S, Preston RA, Chensny LJ et al. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet 1998; 63: 95–100.

    Article  CAS  Google Scholar 

  4. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996; 14: 199–202.

    Article  CAS  Google Scholar 

  5. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863–1870.

    Article  CAS  Google Scholar 

  6. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM . Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004; 13: 763–770.

    Article  CAS  Google Scholar 

  7. Plougastel B, Trowsdale J . Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes. Eur J Immunol 1997; 27: 2835–2839.

    Article  CAS  Google Scholar 

  8. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285: 727–729.

    Article  CAS  Google Scholar 

  9. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999; 285: 730–732.

    Article  CAS  Google Scholar 

  10. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001; 14: 123–133.

    Article  CAS  Google Scholar 

  11. Bacon L, Eagle RA, Meyer M, Easom N, Young NT, Trowsdale J . Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J Immunol 2004; 173: 1078–1084.

    Article  CAS  Google Scholar 

  12. Bahram S, Bresnahan M, Geraghty DE, Spies T . A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1994; 91: 6259–6263.

    Article  CAS  Google Scholar 

  13. Nalabolu SR, Shukla H, Nallur G, Parimoo S, Weissman SM . Genes in a 220-kb region spanning the TNF cluster in human MHC. Genomics 1996; 31: 215–222.

    Article  CAS  Google Scholar 

  14. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, Spies T . Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 1996; 93: 12445–12450.

    Article  CAS  Google Scholar 

  15. Hue S, Monteiro RC, Berrih-Aknin S, Caillat-Zucman S . Potential role of NKG2D/MHC class I-related chain A interaction in intrathymic maturation of single-positive CD8T cells. J Immunol 2003; 171: 1909–1917.

    Article  Google Scholar 

  16. Bilbao JR, Martin-Pagola A, Vitoria JC, Zubillaga P, Ortiz L, Castano L . HLA-DRB1 and MHC class 1 chain-related A haplotypes in Basque families with celiac disease. Tissue Antigens 2002; 60: 71–76.

    Article  CAS  Google Scholar 

  17. Fernandez L, Fernandez-Arquero M, Gual L, Lazaro F, Maluenda C, Polanco I et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene in celiac disease. Tissue Antigens 2002; 59: 219–222.

    Article  CAS  Google Scholar 

  18. Lopez-Vazquez A, Rodrigo L, Fuentes D, Riestra S, Bousono C, Garcia-Fernandez S et al. MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201. Gut 2002; 50: 336–340.

    Article  CAS  Google Scholar 

  19. Ahmad T, Marshall SE, Mulcahy-Hawes K, Orchard T, Crawshaw J, Armuzzi A et al. High resolution MIC genotyping: design and application to the investigation of inflammatory bowel disease susceptibility. Tissue Antigens 2002; 60: 164–179.

    Article  CAS  Google Scholar 

  20. Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P et al. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum Immunol 2003; 64: 816–822.

    Article  CAS  Google Scholar 

  21. Glas J, Martin K, Brunnler G, Kopp R, Folwaczny C, Weiss EH et al. MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. Tissue Antigens 2001; 58: 243–249.

    Article  CAS  Google Scholar 

  22. Sugimura K, Ota M, Matsuzawa J, Katsuyama Y, Ishizuka K, Mochizuki T et al. A close relationship of triplet repeat polymorphism in MHC class I chain-related gene A (MICA) to the disease susceptibility and behavior in ulcerative colitis. Tissue Antigens 2001; 57: 9–14.

    Article  CAS  Google Scholar 

  23. Shum BP, Flodin LR, Muir DG, Rajalingam R, Khakoo SI, Cleland S et al. Conservation and variation in human and common chimpanzee CD94 and NKG2 genes. J Immunol 2002; 168: 240–252.

    Article  CAS  Google Scholar 

  24. Uhrberg M, Valiante NM, Shum BP, Shilling HG, Lienert-Weidenbach K, Corliss B et al. Human diversity in killer cell inhibitory receptor genes. Immunity 1997; 7: 753–763.

    Article  CAS  Google Scholar 

  25. Mandelboim O, Davis DM, Reyburn HT, Vales-Gomez M, Sheu EG, Pazmany L et al. Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 1996; 274: 2097–2100.

    Article  CAS  Google Scholar 

  26. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997; 7: 739–751.

    Article  CAS  Google Scholar 

  27. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO . Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995; 3: 801–809.

    Article  CAS  Google Scholar 

  28. Young NT, Uhrberg M, Phillips JH, Lanier LL, Parham P . Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol 2001; 166: 3933–3941.

    Article  CAS  Google Scholar 

  29. Luszczek W, Manczak M, Cislo M, Nockowski P, Wisniewski A, Jasek M et al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 2004; 65: 758–766.

    Article  CAS  Google Scholar 

  30. Suzuki Y, Hamamoto Y, Ogasawara Y, Ishikawa K, Yoshikawa Y, Sasazuki T et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 2004; 122: 1133–1136.

    Article  CAS  Google Scholar 

  31. Williams F, Meenagh A, Sleator C, Cook D, Fernandez-Vina M, Bowcock AM et al. Activating killer cell immunoglobulin-like receptor gene KIR2DS1 is associated with psoriatic arthritis. Hum Immunol 2005; 66: 836–841.

    Article  CAS  Google Scholar 

  32. Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004; 50: 1561–1565.

    Article  CAS  Google Scholar 

  33. Yen JH, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001; 193: 1159–1167.

    Article  CAS  Google Scholar 

  34. Nikitina-Zake L, Rajalingham R, Rumba I, Sanjeevi CB . Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls. Ann NY Acad Sci 2004; 1037: 161–169.

    Article  CAS  Google Scholar 

  35. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ . KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003; 52: 2639–2642.

    Article  CAS  Google Scholar 

  36. King AL, Yiannakou JY, Brett PM, Curtis D, Morris MA, Dearlove AM et al. A genome-wide family-based linkage study of coeliac disease. Ann Hum Genet 2000; 64: 479–490.

    Article  CAS  Google Scholar 

  37. Moodie SJ, Norman PJ, King AL, Fraser JS, Curtis D, Ellis HJ et al. Analysis of candidate genes on chromosome 19 in coeliac disease: an association study of the KIR and LILR gene clusters. Eur J Immunogenet 2002; 29: 287–291.

    Article  CAS  Google Scholar 

  38. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale J et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200: 957–965.

    Article  CAS  Google Scholar 

  39. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B . Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 2002; 169: 5118–5129.

    Article  Google Scholar 

  40. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM . CD4+, CD28− T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001; 44: 13–20.

    Article  CAS  Google Scholar 

  41. Johansson S, Berg L, Hall H, Hoglund P . NK cells: elusive players in autoimmunity. Trends Immunol 2005; 26: 613–618.

    Article  CAS  Google Scholar 

  42. Auer IO, Ziemer E, Sommer H . Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood. Clin Exp Immunol 1980; 42: 41–49.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Giacomelli R, Passacantando A, Frieri G, Parzanese I, D'Alo S, Vernia P et al. Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients. Clin Exp Immunol 1999; 115: 72–77.

    Article  CAS  Google Scholar 

  44. Manzano L, Alvarez-Mon M, Abreu L, Antonio Vargas J, de la Morena E, Corugedo F et al. Functional impairment of natural killer cells in active ulcerative colitis: reversion of the defective natural killer activity by interleukin 2. Gut 1992; 33: 246–251.

    Article  CAS  Google Scholar 

  45. Karre K, Ljunggren HG, Piontek G, Kiessling R . Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986; 319: 675–678.

    Article  CAS  Google Scholar 

  46. Ljunggren HG, Karre K . In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237–244.

    Article  CAS  Google Scholar 

  47. Winter CC, Gumperz JE, Parham P, Long EO, Wagtmann N . Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 1998; 161: 571–577.

    CAS  PubMed  Google Scholar 

  48. Lennard-Jones JE . Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2–6; discussion 16–19.

    Article  CAS  Google Scholar 

  49. Gomez-Lozano N, Vilches C . Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 2002; 59: 184–193.

    Article  CAS  Google Scholar 

  50. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilising sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355–367.

    Article  CAS  Google Scholar 

  51. Olerup O, Aldener A, Fogdell A . HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 1993; 41: 119–134.

    Article  CAS  Google Scholar 

  52. Bunce M, Barnardo MC, Procter J, Marsh SG, Vilches C, Welsh KI . High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens 1996; 48: 680–691.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

NTY and DCJ are funded by the Leukaemia Research Fund; JT is funded by the Medical Research Council and the Wellcome Trust.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N T Young.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, D., Edgar, R., Ahmad, T. et al. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility. Genes Immun 7, 576–582 (2006). https://doi.org/10.1038/sj.gene.6364333

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364333

Keywords

This article is cited by

Search

Quick links